Catalyst Biosciences Inc (NASDAQ:CBIO) Announces Helpful Factor IX Clinical Data
Catalyst Biosciences Inc (NASDAQ:CBIO) announced recently that they have successfully achieved the positive clinical data from its ongoing Phase 1/2 clinical data in the participants […]